39.1
Insight Molecular Diagnostics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
25.5
FY23:
10.7
FY24:
11.8
FY25:
15.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
120
FY22:
74.6
FY23:
64.2
FY24:
23.3
FY25:
10.5
Total assets
Change from FY21 to FY25
millions USD
FY21:
160
FY22:
100
FY23:
74.9
FY24:
35.1
FY25:
25.8
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
14.1
FY22:
12.1
FY23:
7.19
FY24:
7.28
FY25:
12.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
80.2
FY22:
48.4
FY23:
42.1
FY24:
40.1
FY25:
45.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
65.2
FY22:
34.3
FY23:
20.5
FY24:
−12.3
FY25:
−31.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
160
FY22:
–
FY23:
–
FY24:
35.1
FY25:
25.8
All amounts in millions USD